Insights on the implementation strategies for a potential new tuberculosis vaccine in South Africa
Examines how a potential new TB vaccine could be introduced in South Africa. Interviews with 26 stakeholders explored implementation priorities, target populations, vaccine price, cost-effectiveness, regulatory approval, financing, procurement, delivery logistics, vaccine acceptability and lessons from existing vaccination programmes.
Project details
Country
Timeline
Target group
Vaccine
Type of protection of vaccine
Type of research
Partners involved
Africa Health Research Institute, Clinton Health Access Initiative (CHAI), London School of Hygiene & Tropical Medicine, South African Medical Research Council, South African National Department of Health, The Aurum Institute, University of KwaZulu-Natal, University of Pretoria, University of the Witwatersrand, Vanderbilt University, Wits Health Consortium